2254
Thrombotic thrombocytopenic purpura (TTP) developed in a patient with seropositive rheumatoid arthritis (RA) after 2 1/2 months of treatment with penicillamine.
 a patient with seropositive rheumatoid arthritis (RA): Subject; Thrombotic thrombocytopenic purpura (TTP): Effect; 2 1/2 months of treatment with penicillamine: Treatment; rheumatoid arthritis: Treatment.Disorder; penicillamine: Treatment.Drug; 2 1/2 months: Treatment.Duration
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a patient with seropositive rheumatoid arthritis (RA): Subject; Thrombotic thrombocytopenic purpura (TTP): Effect; 2 1/2 months of treatment with penicillamine: Treatment; rheumatoid arthritis: Treatment.Disorder; penicillamine: Treatment.Drug; 2 1/2 months: Treatment.Duration